Skip to main content

Proactive news headlines including Archer Materials, Lake Resources, Anson Resources and Prescient Therapeutics

Sydney, Sept. 14, 2022 (GLOBE NEWSWIRE) — Proactive, provider of real-time news and video interviews on growth companies listed in Australia, has covered the following companies:

  • Archer Materials Ltd (ASX:AXE, OTC:ARRXF) is developing a qubit processor chip that could potentially operate at room temperature and integrate into modern electronics. Click here
  • Lake Resources NL (ASX:LKE, OTCQB:LLKKF) has gained a ‘speculative buy’ recommendation and a valuation of A$2.54 per share from Bell Potter Securities, as the company advances its Kachi Lithium Project in Argentina into development. Click here
  • Anson Resources Ltd (ASX:ASN) has wrapped up resource definition drilling at Cane Creek 32-1 well at the Paradox Lithium Project in Utah, USA, with initial assay results confirming the project’s resource expansion potential. Click here
  • Prescient Therapeutics Ltd (ASX:PTX) has been invited to present two sessions at the upcoming CAR-TCR Summit in Boston on September 19 to 22, during which the clinical stage oncology company will also unveil CellPryme-A, the enhanced component of its cell therapy platform CellPryme. Click here
  • Altech Chemicals Ltd (ASX:ATC) is trading higher after executing a Joint Venture Shareholders’ Agreement with leading German battery institute Fraunhofer IKTS to commercialise IKTS’ revolutionary CERENERGY® Sodium Alumina Solid State (SAS) Battery that is free of lithium, graphite, copper and cobalt. Click here
  • Tietto Minerals Ltd (ASX:TIE) remains on track for the first gold pour during the December quarter at its 3.45-million-ounce Abujar Gold Project in Côte d’Ivoire, West Africa. Click here
  • Surefire Resources NL (ASX:SRN) has confirmed the presence of lead and silver mineralisation through rock chip sampling at Mt Conspicuous prospect of the Kooline Project in Western Australia. Click here
  • Creso Pharma Ltd (ASX:CPH, OTCQB:COPHF) wholly-owned Canadian-based psychedelics subsidiary Halucenex Life Sciences Inc. has kicked off Phase 2 of its psilocybin clinical trial after securing the approval of the Research Ethics Board (REB). Click here
  • Radiopharm Theranostics Ltd (ASX:RAD) and the University of Texas MD Anderson Cancer Center have launched Radiopharm Ventures, LLC, a joint venture company created to develop novel radiopharmaceutical therapeutic products for cancer. Click here
  • Lake Resources NL (ASX:LKE, OTCQB:LLKKF) and its technology partner Lilac Solutions Inc have completed two key milestones in an earn-in agreement between the two companies, allowing Lilac Solutions to buy-in to the Kachi Project with a stake of up to 25%. Click here
  • Noxopharm Ltd (ASX:NOX) has delivered encouraging preclinical data from its novel ‘dual-cell’ therapy drug that attacks pancreatic cancer in a different and innovative way. Click here
  • Duke Exploration Ltd (ASX:DEX) is confident that exploration, including drilling, at its flagship Bundarra project in central Queensland will lead to the identification of further resources for future campaigns. Click here
  • Frontier Energy Ltd (ASX:FHE) has agreed to access water for its green hydrogen facility at the Bristol Springs Renewable Energy Project from the existing Stirling Trunk Main pipeline, a major milestone achieved in consultation with the Western Australian Government-owned Water Corporation. Click here
  • Kin Mining NL (ASX:KIN) has completed a capital raising of $13.7 million with a $4 million non-renounceable rights issue, undertaken on the basis of 1 new share for every 7 shares held at $0.075 per new share, to be issued on September 14. Click here
  • Moho Resources Ltd (ASX:MOH) has developed a portfolio of strategically located rare earth element (REE) projects in Western Australia which it intends to explore, develop and capitalise on to meet a predicted global shortage of REEs. Click here

About Proactive

  • Proactive is a unique tech-enabled platform providing companies globally with a comprehensive investor engagement solution across their business lifecycle.
  • With six offices on three continents, Proactive works with innovative growth companies quoted on the world’s major stock exchanges, helping executives to engage intelligently with investors.
  • In 2020, Proactive featured in 809 million search results, our content was viewed over 165 million times and our readers spent over 10 million hours on our websites. Proactive has produced over 300,000 articles and 20,000 executive interviews since it was established in 2006.

For more information on how Proactive can help you make a difference, email us at action@proactiveinvestors.com

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.